Literature DB >> 3194846

An expanded view of risk-group definition in differentiated thyroid carcinoma.

B Cady1, R Rossi.   

Abstract

There continues to be controversy about every aspect of management of differentiated thyroid carcinoma. In an age-based risk group previously described, low-risk patients made up 62% of cases and had a death rate of only 1%. Recent reports from the Mayo Clinic have expanded the concept of the low-risk group to include 86% of all cases with a 2% death rate by utilizing several anatomic and pathologic criteria of risk. We offer here another multifactorial system for the identification of low-risk patients who made up 89.4% of all patient seen between 1961 and 1980 and who have a death rate of only 1.8%. The resultant high-risk group constitutes 11% of cases but carries a 46% mortality rate. The risk-group definition is completely clinical and is based on age, presence of distant metastases, and the size and extent of primary cancer. It can be used confidently at the operating table to select conservative surgical procedures in patients with negligible risk of death. Through the succeeding decades analyzed, from 1941 to 1980, the effectiveness of this clinical categorization has increased substantially in separating patients at high and low risk, so that a mortality rate ratio of 26:1 now exists between high- and low-risk groups, respectively.

Entities:  

Mesh:

Year:  1988        PMID: 3194846

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  179 in total

Review 1.  Thyroid cancer surgery.

Authors:  R Udelsman
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Thyroid cancer presentation and treatment in the United States.

Authors:  Lindsey Enewold; Linda C Harlan; Jennifer L Stevens; Elad Sharon
Journal:  Ann Surg Oncol       Date:  2014-11-01       Impact factor: 5.344

3.  Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database.

Authors:  Ryan K Orosco; Timon Hussain; Kevin T Brumund; Deborah K Oh; David C Chang; Michael Bouvet
Journal:  Thyroid       Date:  2015-01       Impact factor: 6.568

4.  A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis.

Authors:  Muneki Hotomi; Iwao Sugitani; Kazuhisa Toda; Kazuyoshi Kawabata; Yoshihide Fujimoto
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

5.  Prognostic factors of papillary thyroid carcinoma vary according to sex and patient age.

Authors:  Yasuhiro Ito; Takumi Kudo; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

6.  Recurrent differentiated thyroid cancer: to cut or burn.

Authors:  Roberto Cirocchi; Stefano Trastulli; Alessandro Sanguinetti; Lorenzo Cattorini; Piero Covarelli; Domenico Giannotti; Giorgio Di Rocco; Fabio Rondelli; Francesco Barberini; Carlo Boselli; Alberto Santoro; Nino Gullà; Adriano Redler; Nicola Avenia
Journal:  World J Surg Oncol       Date:  2011-08-12       Impact factor: 2.754

7.  Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.

Authors:  David F Schneider; Dawn Elfenbein; Ricardo V Lloyd; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2014-08-05       Impact factor: 5.344

8.  Extent of surgery affects survival for papillary thyroid cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti; Cord Sturgeon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

9.  The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.

Authors:  Kyubo Kim; Jin Hwan Kim; Il Seok Park; Young Soo Rho; Gee Hwan Kwon; Dong Jin Lee
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

10.  Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006.

Authors:  Clive S Grant; John M Stulak; Geoffrey B Thompson; Melanie L Richards; Carl C Reading; Ian D Hay
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.